81 FR 35034 - National Heart, Lung, and Blood Institute; Notice of Closed Meeting
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 81, Issue 105 (June 1, 2016)
National Institutes of Health
Federal Register Volume 81, Issue 105 (June 1, 2016)
| Page Range | 35034-35034 | |
| FR Document | 2016-12756 |
[Federal Register Volume 81, Number 105 (Wednesday, June 1, 2016)] [Notices] [Page 35034] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-12756] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Heart, Lung, and Blood Initial Review Group; Clinical Trials Review Committee. Date: June 23-24, 2016. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Garden Inn Bethesda, 7301 Waverly Street, Bethesda, MD 20814. Contact Person: Keary A. Cope, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7190, Bethesda, MD 20892-7924, 301-435-2222, [email protected]. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: May 25, 2016. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016-12756 Filed 5-31-16; 8:45 am] BILLING CODE 4140-01-P
![35034 Federal Register / Vol. 81, No. 105 / Wednesday, June 1, 2016 / Notices
HRSA, either by email to OIRA_ opioid overdose and training of licensed Likely Respondents: Rural Opioid
submission@omb.eop.gov or by fax to healthcare professionals and emergency Overdose Reversal Grant Program award
202–395–5806. responders on their use. recipients.
FOR FURTHER INFORMATION CONTACT: To
Need and Proposed Use of the
Burden Statement: Burden in this
request a copy of the clearance requests Information: For this program,
performance measures were drafted to context means the time expended by
submitted to OMB for review, email the persons to generate, maintain, retain,
HRSA Information Collection Clearance provide data useful to the program and
to enable HRSA to provide aggregate disclose or provide the information
Officer at paperwork@hrsa.gov or call requested. This includes the time
(301) 443–1984. program data required by Congress
under the Government Performance and needed to review instructions; to
SUPPLEMENTARY INFORMATION: Results Act (GPRA) of 1993 (Public Law develop, acquire, install and utilize
Information Collection Request Title: 103–62). These measures cover the technology and systems for the purpose
Rural Opioid Overdose Reversal Grant principal topic areas of interest to the of collecting, validating and verifying
Program OMB No. 0906–xxxx—New. Federal Office of Rural Health Policy, information, processing and
Abstract: This program is authorized including: (a) The number of counties maintaining information, and disclosing
by Section 711(b) of the Social Security served by the program; (b) the number and providing information; to train
Act (U.S.C. 912(b), as amended and the and type of devices purchased and personnel and to be able to respond to
Consolidated and Further Continuing distributed and the location of the a collection of information; to search
Appropriations Act (P.L. 113–235). The distribution; (c) the number of training data sources; to complete and review
purpose of this grant program is to sessions and the number of individuals the collection of information; and to
reduce the incidences of morbidity and trained; and (d) the number of transmit or otherwise disclose the
mortality related to opioid overdoses in individuals who were administered information. The total annual burden
rural communities through the purchase Narcan and the outcome. These hours estimated for this ICR are
and placement of emergency devices measures will speak to the Office’s summarized in the table below.
used to rapidly reverse the effects of progress toward meeting the set goals.
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Average
Number of
Number of Total burden per Total burden
Form name responses per
respondents responses response hours
respondent (in hours)
Rural Opioid Overdose Reversal Grant Program Perform-
ance Measures ................................................................. 18 1 18 4 72
Total .............................................................................. 18 ........................ 18 ........................ 72
Jason E. Bennett, Name of Committee: Heart, Lung, and DEPARTMENT OF HEALTH AND
Director, Division of the Executive Secretariat. Blood Initial Review Group; Clinical Trials HUMAN SERVICES
[FR Doc. 2016–12745 Filed 5–31–16; 8:45 am] Review Committee.
BILLING CODE 4165–15–P
Date: June 23–24, 2016. National Institutes of Health
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant National Heart, Lung, and Blood
DEPARTMENT OF HEALTH AND applications. Institute; Notice of Closed Meeting
HUMAN SERVICES Place: Hilton Garden Inn Bethesda, 7301
Waverly Street, Bethesda, MD 20814. Pursuant to section 10(d) of the
National Institutes of Health Contact Person: Keary A. Cope, Ph.D., Federal Advisory Committee Act, as
Scientific Review Officer, Office of Scientific amended (5 U.S.C. App.), notice is
National Heart, Lung, and Blood Review/DERA, National Heart, Lung, and hereby given of the following meeting.
Institute; Notice of Closed Meeting Blood Institute, 6701 Rockledge Drive, Room The meeting will be closed to the
7190, Bethesda, MD 20892–7924, 301–435– public in accordance with the
Pursuant to section 10(d) of the 2222, copeka@mail.nih.gov. provisions set forth in sections
Federal Advisory Committee Act, as (Catalogue of Federal Domestic Assistance 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
amended (5 U.S.C. App.), notice is Program Nos. 93.233, National Center for as amended. The grant applications and
hereby given of the following meeting. Sleep Disorders Research; 93.837, Heart and the discussions could disclose
The meeting will be closed to the Vascular Diseases Research; 93.838, Lung confidential trade secrets or commercial
public in accordance with the Diseases Research; 93.839, Blood Diseases property such as patentable material,
provisions set forth in sections and Resources Research, National Institutes and personal information concerning
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., of Health, HHS) individuals associated with the grant
as amended. The grant applications and Dated: May 25, 2016. applications, the disclosure of which
the discussions could disclose
sradovich on DSK3TPTVN1PROD with NOTICES
Michelle Trout, would constitute a clearly unwarranted
confidential trade secrets or commercial invasion of personal privacy.
property such as patentable material, Program Analyst, Office of Federal Advisory
Committee Policy. Name of Committee: Heart, Lung, and
and personal information concerning Blood Initial Review Group; NHLBI
individuals associated with the grant [FR Doc. 2016–12756 Filed 5–31–16; 8:45 am]
Mentored Clinical and Basic Science Review
applications, the disclosure of which BILLING CODE 4140–01–P Committee.
would constitute a clearly unwarranted Date: June 23–24, 2016.
invasion of personal privacy. Time: 10:30 a.m. to 11:00 a.m.
VerDate Sep<11>2014 21:59 May 31, 2016 Jkt 238001 PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 E:\FR\FM\01JNN1.SGM 01JNN1](https://thefederalregister.org/doc/81_FR_35139/page/1.svg)
Document Created: 2018-02-08 07:27:27
Document Modified: 2018-02-08 07:27:27
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | June 23-24, 2016. | |
| FR Citation | 81 FR 35034 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR